Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Deep Track Capital, LP (CIK 1856083) reported $6.12B across 57 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: XBI ($1.28B, 20.86%), GH ($308.4M, 5.04%), IMVT ($286.3M, 4.68%), TARS ($252.5M, 4.12%), PCVX ($249.9M, 4.08%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | XBI | SPDR SERIES TRUST | $1.28B | 20.86% | 10.0M | Hold |
| 2 | GH | GUARDANT HEALTH INC | $308.4M | 5.04% | 3.3M | Added |
| 3 | IMVT | IMMUNOVANT INC | $286.3M | 4.68% | 11.5M | Hold |
| 4 | TARS | TARSUS PHARMACEUTICALS INC | $252.5M | 4.12% | 3.6M | Added |
| 5 | PCVX | VAXCYTE INC | $249.9M | 4.08% | 4.3M | Added |
| 6 | GPCR | STRUCTURE THERAPEUTICS INC | $206.3M | 3.37% | 4.3M | Added |
| 7 | AXSM | AXSOME THERAPEUTICS INC. | $185.9M | 3.04% | 1.1M | Trimmed |
| 8 | APLS | APELLIS PHARMACEUTICALS INC | $182.3M | 2.98% | 4.5M | Trimmed |
| 9 | OCUL | OCULAR THERAPEUTIX INC | $166.7M | 2.72% | 19.7M | Added |
| 10 | VERA | VERA THERAPEUTICS INC | $165.2M | 2.70% | 4.1M | Added |
| 11 | ALMS | ALUMIS INC | $149.2M | 2.44% | 6.8M | New |
| 12 | IONS | IONIS PHARMACEUTICALS INC | $146.4M | 2.39% | 1.9M | Added |
| 13 | NUVL | NUVALENT INC | $141.0M | 2.30% | 1.4M | New |
| 14 | ALKS | ALKERMES PLC | $127.0M | 2.07% | 3.6M | Added |
| 15 | CNTA | CENTESSA PHARMACEUTICALS PLC | $125.4M | 2.05% | 3.2M | Added |
| 16 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $119.5M | 1.95% | 6.4M | Added |
| 17 | MAZE | MAZE THERAPEUTICS INC | $103.8M | 1.70% | 3.5M | Trimmed |
| 18 | ORKA | ORUKA THERAPEUTICS INC | $99.8M | 1.63% | 2.0M | Trimmed |
| 19 | GMAB | GENMAB A/S | $98.3M | 1.61% | 3.7M | New |
| 20 | NRIX | NURIX THERAPEUTICS INC | $98.4M | 1.61% | 6.3M | Trimmed |
| 21 | CYTK | CYTOKINETICS INC | $90.6M | 1.48% | 1.4M | Trimmed |
| 22 | GRAL | GRAIL INC | $89.0M | 1.45% | 1.7M | Added |
| 23 | LB PHARMACEUTICALS INC | $82.7M | 1.35% | 3.4M | Hold | |
| 24 | MBX | MBX BIOSCIENCES INC | $82.3M | 1.34% | 2.8M | Trimmed |
| 25 | BCAX | BICARA THERAPEUTICS INC | $80.8M | 1.32% | 4.1M | Added |
Source: SEC Form 13F filings · as of 2026-03-31